About us
We make your injectables work. Better, longer and with fewer side effects. We take pride in going the extra mile when turning…
Our services
OctoPlus develops injectable dosage forms for optimized administration of medicines. We cover this process from the lab bench…
Corporate information
OctoPlus is a specialty pharmaceutical company focused on the formulation development and cGMP manufacturing of controlled…
News and events
Here you find the latest news, press releases and events of OctoPlus
OctoPlus' Annual General Meeting of shareholders will be held on 28 June
Click here for the full press release Leiden, the Netherlands, 13 June 2013 – OctoPlus N.V. ("OctoPlus" or the "Company") announces that its Annual General Meeting of Shareholders will be held at the Company's…
Developments in the Market Place - Nanomedicine developed for Acute Lung Injury
Acute Lung Injury or ALI is a serious condition and leads to death by lung failure in many patients. Especially uncontrolled inflammation leads to severe problems. Researchers now designed an interesting nanomedicine.…
More news
Developements in the Market Place - New delivery for cancer drugs
- TNF-alpha is a protein that could have been ideal as an anti-cancer drug.…
Developments in the Market Place - Degradation of PLGA nanoparticles in live tissue
- Researchers examined how PLGA nanoparticles break down in live tissues.…
Meet OctoPlus at the BOS CMC event in Copenhagen.
- OctoPlus will be present during the BOS CMC event, scheduled to…